Expert Opinion on Therapeutic Targets

Identifying targets for drug discovery using bioinformatics
pp. 383-389(7)
Authors: Phoebe Chen, Yi-Ping; Chen, Feng

New therapeutic targets in immune disorders: ItpkB, Orai1 and UNC93B
pp. 391-413(23)
Authors: Huang, Yina H; Hoebe, Kasper; Sauer, Karsten

Cysteinyl leukotriene receptor CysLT₁ as a novel therapeutic target for allergic rhinitis treatment
pp. 415-423(9)
Author: Shirasaki, Hideaki

Potential therapeutic targets for Parkinson's disease
pp. 425-436(12)
Author: Stoessl, Jon

Neurotrophic factors as a therapeutic target for Parkinson's disease
pp. 437-447(11)
Authors: Evans, Jonathan R; Barker, Roger A

Therapeutic targets for medulloblastoma
pp. 449-461(13)
Authors: Wlodarski, Pawel K; Jozwiak, Jaroslaw

Targeting survivin in cancer therapy
pp. 463-476(14)
Authors: Pennati, Marzia; Folini, Marco; Zaffaroni, Nadia

Targeting the TCR signaling checkpoint: a therapeutic strategy to reactivate memory T cells in the tumor microenvironment
pp. 477-490(14)
Authors: Simpson-Abelson, Michelle; Bankert, Richard B

ABCA2 as a therapeutic target in cancer and nervous system disorders
pp. 491-504(14)
Authors: Mack, Jody T; Brown, Carol B; Tew, Kenneth D

The yeast two-hybrid system and its role in drug discovery
pp. 505-515(11)
Authors: Lentze, Nicolas; Auerbach, Daniel

Corrigendum
pp. 517-517(1)